Cargando…
Optimization of a tri-drug treatment against lung cancer using orthogonal design in preclinical studies
A growing body of evidence suggests that anesthetics impact the outcome of patients with cancer after surgical intervention. However, the optimal dose and underlying mechanisms of co-administered anesthetics in lung tumor therapy have been poorly studied. Here, we aimed to investigate the role of co...
Autores principales: | Tan, Jing, Wang, Lijun, Song, Xuming, Zhang, Yijian, Song, Zhenghuan, Duan, Manlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340110/ https://www.ncbi.nlm.nih.gov/pubmed/37456863 http://dx.doi.org/10.7717/peerj.15672 |
Ejemplares similares
-
TRiC’s tricks inhibit huntingtin aggregation
por: Shahmoradian, Sarah H, et al.
Publicado: (2013) -
Inhibition of Kelch-like epichlorohydrin-related protein 1 promotes the progression and drug resistance of lung adenocarcinoma
por: Gao, Hong, et al.
Publicado: (2021) -
Preclinical models of acute liver failure: a comprehensive review
por: Hefler, Joshua, et al.
Publicado: (2021) -
A composite double-/single-stranded RNA-binding region in protein Prp3 supports tri-snRNP stability and splicing
por: Liu, Sunbin, et al.
Publicado: (2015) -
Design of new acid-activated cell-penetrating peptides for tumor drug delivery
por: Yao, Jia, et al.
Publicado: (2017)